Fineline Cube

Follow:
14398 Articles
Sino Biopharmaceutical's Anlotinib Receives Ninth Indication Approval from China's CDE for Soft-Tissue Sarcoma
CompanyDrug

Sino Biopharmaceutical’s Anlotinib Receives Ninth Indication Approval from China’s CDE for Soft-Tissue Sarcoma

GenScript Dissolves Merger with CAR-T Specialist Legend Biotech, Reclassifies as Associated Company
Company

GenScript Dissolves Merger with CAR-T Specialist Legend Biotech, Reclassifies as Associated Company

China's NMPA Greenlights Pilot Plan for Phased Manufacturing of Biological Products
Policy / Regulatory

China’s NMPA Greenlights Pilot Plan for Phased Manufacturing of Biological Products

Otsuka Holdings Weighs Sale of Stake in Medical Device Maker MicroPort Scientific
CompanyDeals

Otsuka Holdings Weighs Sale of Stake in Medical Device Maker MicroPort Scientific

CompanyDeals

Dongcheng Pharma Moves to Enhance Portfolio with Acquisition of Rongcheng Medical’s GSA Injection

Johnson & Johnson's Akeega Approved in China as First Dual Action Tablet for mCRPC
CompanyDrug

Johnson & Johnson’s Akeega Approved in China as First Dual Action Tablet for mCRPC

Everest Medicines' Nefecon Approved in Taiwan for Primary IgAN Treatment
CompanyDrug

Everest Medicines’ Nefecon Approved in Taiwan for Primary IgAN Treatment

BeiGene's Tevimbra Approved in China for NSCLC Patients as Neoadjuvant and Adjuvant Therapy
CompanyDrug

BeiGene’s Tevimbra Approved in China for NSCLC Patients as Neoadjuvant and Adjuvant Therapy

Tianjin Municipality Unveils Plan to Boost Synthetic Biology and Biomanufacturing Innovation
Policy / Regulatory

Tianjin Municipality Unveils Plan to Boost Synthetic Biology and Biomanufacturing Innovation

Novo Nordisk's Alhemo Receives CHMP Recommendation for Haemophilia Prophylaxis in Europe
CompanyDrug

Novo Nordisk’s Alhemo Receives CHMP Recommendation for Haemophilia Prophylaxis in Europe

Stem-Cell Startup Xellsmart Secures Over RMB 100 Million in Series B1 Financing for Neurological Therapies
CompanyDeals

Stem-Cell Startup Xellsmart Secures Over RMB 100 Million in Series B1 Financing for Neurological Therapies

Novartis's Kisqali Receives Positive CHMP Opinion for Early Breast Cancer Treatment in the EU
CompanyDrug

Novartis’s Kisqali Receives Positive CHMP Opinion for Early Breast Cancer Treatment in the EU